Patently-O

SEPTEMBER 26, 2022

A quick recap: Despite dozens of interesting and important cases, the Supreme Court denied all petitions for writ of certiorari for the 2021-2022 term. Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?)

Patent Law 126

Patent Law Law Patent Invention 126

Patently-O

FEBRUARY 24, 2022

The Supreme Court has not yet granted writ of certiorari in any patent cases this term. And, absent an unusual shadow-docket patent case, it is now too late for any case to be granted and heard this term. Rather, any new grant this term will very likely be pushed back to the October 2022 Term for hearing and decision. Genentech, Inc. ,

Patent Law 95

Patent Law Law Patent Litigation 95

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 7, 2022

Filings at the PTAB in 2021 also reflect a general slowdown, with a decline of about 10% from 2020. [1] 1] Nevertheless, the PTAB remains the most active forum for patent disputes nationwide, handling significantly more matters in 2021 than both the Eastern and Western Districts of Texas and the District of Delaware. [2]. Download a PDF.

Reporting 52

Reporting Art Invention Patent 52